Parallel Fluidics
PrivateLast Round
Seed
Nov 7, 2024
Est. Valuation
$22.29M
Total Funding Raised
$9.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Parallel Fluidics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in November 2024.
Parallel Fluidics is a manufacturing company that provides an on-demand microfluidic manufacturing service for scientific teams in areas such as diagnostics, drug discovery, and cell therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parallel Fluidics Comparables
Compare Parallel Fluidics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uFluidix | 80% | |
| Eden Tech | 79% | |
| Hangzhou TinkerBio Technology Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Parallel Fluidics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 7, 2024 | ||||
| Seed | Nov 23, 2021 | ||||
| Grant | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Parallel Fluidics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Praxis | Seed |
| J2 Ventures | Seed |
| 8VC | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 36% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 12, 2026
Parallel Fluidics, Inc. and Formulatrix partner to enable automated lipid nanoparticle screening on the Formulatrix FLO i8 PD, uniting microfluidic formulation and liquid handling in a single screening process in Massachusetts on Aug 13th '26.
For institutional investors. Book with your work email.
Parallel Fluidics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Parallel Fluidics's valuation, stock price, and market status.
Is Parallel Fluidics a public or private company?
Parallel Fluidics is a private company.
What is the current stock price of Parallel Fluidics?
Parallel Fluidics is a private company, so its shares have no public market price. Caplight tracks Parallel Fluidics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Parallel Fluidics worth (valuation)?
Parallel Fluidics's valuation is estimated at $22.3M based on funding round data.
Can I buy Parallel Fluidics stock?
Parallel Fluidics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Parallel Fluidics's last funding round?
Parallel Fluidics's most recent funding round was Seed on November 7, 2024.
Who are the main investors in Parallel Fluidics?
Key investors in Parallel Fluidics include J2 Ventures.
Will Parallel Fluidics IPO soon?
No public IPO plans have been announced for Parallel Fluidics.
How can I track Parallel Fluidics secondary market activity?
Caplight tracks bids, offers, and trades in Parallel Fluidics's shares on secondary markets.